TAT and several other markers demonstrated an ability to predict the development of venous thromboembolism in patients with cervical cancer.

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Patients that receive virtual cardiac rehabilitation have improved hospital admission and emergency department visit rates.

The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.

The majority of US adults use a device on a regular basis to monitor their heart health, but only 1 in 4 uses those data to have a conversation about their heart health with their doctor.

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Higher FT4 levels were associated with increased risks for knee OA prevalence, severity, and progression, especially among patients with greater joint loading.

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to a study.

Increased postoperative opioid consumption was associated with higher probability of new persistent opioid use in opioid-naive patients.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.